Amundi Bausch Health Companies Inc. Transaction History

Amundi

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $128,304 - $258,008	-28,014 Reduced 18.38%	124,398 $943,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $159,683 - $534,463	22,618 Added 17.43%	152,412 $1.33 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $20,628 - $26,539	955 Added 0.74%	129,794 $3.03 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $361,813 - $456,356	15,731 Added 13.91%	128,839 $3.45 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $159,579 - $191,572	6,373 Added 5.97%	113,108 $3.15 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $2.93 Million - $3.49 Million	106,735 New	106,735 $3.13 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.